Fact CheckerSign in

NCT05105633RecruitingPhase 2/3

Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

Extending the Time Window for Tenecteplase by Effective RecanalizatioN of bAsilar Artery occLusion in Patients With POSTerior Circulation Stroke (POST-ETERNAL)

Source: ClinicalTrials.gov · Last updated 6 May 2026

Brief summary (registry, in English)

Patients presenting to the emergency department with an acute ischemic stroke due to basilar artery occlusion within 24 hours of stroke onset will be assessed to determine their eligibility for randomization into the trial. If the patient gives informed consent they will be randomised 50:50 using a central computerised allocation process to either standard of care (no intravenous thrombolytic treatment or intravenous alteplase 0.9mg/kg) or tenecteplase 0.25mg/kg before undergoing mechanical thrombectomy as required at treating clinician's discretion. The trial is Multi-arm, Multi-stage, prospective, randomised, open-label, blinded endpoint (PROBE) design with seamless phase 2b/3 transition if the intermediate endpoint (recanalization without symptomatic intracerebral hemorrhage) is met in analysis of the first 202 patients. Adaptive sample size re-estimation (Mehta and Pocock) will be performed when 240 patients have completed 3 month follow-up (minimum sample size 320, maximum sample size 688).

Status (registry)
Recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
688 (estimated)
First submitted
21 Oct 2021
Start date
29 Nov 2021
Primary completion date
May 2028
Lead sponsor
University of Melbourne
Diseases
Stroke
NCT number
NCT05105633
EU CT number
2024-513444-28-00

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 688
  • From 29 Nov 2021 to the primary completion date, May 2028
  • 31 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pre-stroke mRS of ≥4 (indicating moderate to severe previous disability).
  • Current participation in another research drug treatment protocol.

Other illness

  • Intracerebral hemorrhage (ICH) or other diagnosis (e.g. tumour) identified by baseline imaging.
  • Posterior circulation Acute Stroke Prognosis Early CT score (pc-ASPECTS) \<7 on non-contrast CT, CT Angiography source images or DWI MRI.
  • Strong suspicion of underlying intracranial atherosclerotic disease (e.g diffuse arterial calcifications, basilar stenosis) or dissection which may require immediate neuro-interventional procedure with intracranial stenting and not benefit from intravenous thrombolysis at investigator's discretion.
  • Known terminal illness such that the patients would not be expected to survive a year.
  • Any condition that, in the judgment of the investigator could impose hazards to the patient if study therapy is initiated or affect the participation of the patient in the study.

Other

  • Significant cerebellar mass effect or acute hydrocephalus.
  • Established frank hypodensity on non-contrast CT indicating subacute infarction.
  • Bilateral extensive brainstem ischemia.
  • Other standard contraindications to intravenous thrombolysis.
  • Contraindication to imaging with contrast agents.
  • Clinically evident pregnant women.
  • Planned withdrawal of care or comfort care measures.

Who the study is looking for

  • Patients presenting with posterior circulation ischemic stroke symptoms due to partial or complete basilar artery occlusion within 24 hours from symptom onset (or clinical deterioration/coma) or the time the patient was last known to be well.
  • Patient's age is ≥18 years
  • Presence of basilar artery occlusion, proven by CT Angiography or MR Angiography. Basilar artery occlusion is defined as 'potentially retrievable' occlusion at the basilar artery. This can be a partial or complete occlusion.
  • Premorbid mRS ≤3 (independent function or requiring only minor domestic assistance and able to manage alone for at least 1 week).
  • Local legal requirements for consent have been satisfied.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (31)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Royal Adelaide Hospital
Coordinator of this site? Confirm its status
AdelaideAustraliaRecruiting
Grampians Health
Coordinator of this site? Confirm its status
BallaratAustraliaRecruiting
Bankstown-Lidcombe Hospital
Coordinator of this site? Confirm its status
BankstownAustraliaNot yet recruiting
Gold Coast Hospital
Coordinator of this site? Confirm its status
Gold CoastAustraliaNot yet recruiting
Monash Health
Coordinator of this site? Confirm its status
MelbourneAustraliaNot yet recruiting
Western Health
Coordinator of this site? Confirm its status
MelbourneAustraliaRecruiting
Northern Hospital
Coordinator of this site? Confirm its status
MelbourneAustraliaRecruiting
Austin Hospital
Coordinator of this site? Confirm its status
MelbourneAustraliaRecruiting
Royal Melbourne Hospital
Coordinator of this site? Confirm its status
MelbourneAustraliaRecruiting
Box Hill Hospital
Coordinator of this site? Confirm its status
MelbourneAustraliaRecruiting
Alfred Health
Coordinator of this site? Confirm its status
MelbourneAustraliaRecruiting
Fiona Stanley Hospital
Coordinator of this site? Confirm its status
MurdochAustraliaRecruiting
John Hunter Hospital
Coordinator of this site? Confirm its status
NewcastleAustraliaNot yet recruiting
Liverpool Hospital
Coordinator of this site? Confirm its status
SydneyAustraliaRecruiting
Princess Alexandra Hospital
Coordinator of this site? Confirm its status
WoolloongabbaAustraliaRecruiting
Hospital Geral de Fortaleza
Coordinator of this site? Confirm its status
FortalezaBrazilRecruiting
Centre hospitalier Universitaire de Bordeaux
Coordinator of this site? Confirm its status
BordeauxFranceRecruiting
Centre Hospitalier De Versailles
Coordinator of this site? Confirm its status
Le Chesnay RocquencourtFranceRecruiting
Centre Hospitalier Universitaire De Lille
Coordinator of this site? Confirm its status
Lille CedexFranceRecruiting
Centre Hospitalier Regional De Marseille
Coordinator of this site? Confirm its status
MarseilleFranceRecruiting
Centre Hospitalier Universitaire De Montpellier
Coordinator of this site? Confirm its status
Montpellier Cedex 5FranceRecruiting
CHRU de Nancy
Coordinator of this site? Confirm its status
NancyFranceRecruiting
Centre Hospitalier Universitaire D Orleans
Coordinator of this site? Confirm its status
Orleans Cedex 2FranceRecruiting
Fondation A. de Rothschild
Coordinator of this site? Confirm its status
ParisFranceRecruiting
GIE Groupe hospitalier Paris Saint-Joseph/Vinci
Coordinator of this site? Confirm its status
Paris Cedex 14FranceRecruiting
Centre Hospitalier De Perpignan
Coordinator of this site? Confirm its status
Perpignan CedexFranceRecruiting
Centre Hospitalier Universitaire Reims
Coordinator of this site? Confirm its status
Reims CedexFranceRecruiting
Centre Hospitalier Universitaire de Rennes
Coordinator of this site? Confirm its status
RennesFranceRecruiting
Centre Hospitalier Universitaire Rouen
Coordinator of this site? Confirm its status
Rouen CedexFranceRecruiting
Centre Hospitalier Universitaire de Nantes
Coordinator of this site? Confirm its status
Saint-HerblainFranceRecruiting
Centre Hospitalier Regional Universitaire De Tours
Coordinator of this site? Confirm its status
Tours Cedex 9FranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.